Alkermes (ALKS) Total Debt (2011 - 2026)

Alkermes (ALKS) reported Total Debt of $1.5 billion for Q1 2026, up 422.93% quarter-over-quarter from $288.8 million in Q3 2024.

Alkermes (ALKS) Total Debt (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 15 years of Total Debt data on file, last reported at $1.5 billion in Q1 2026.

  • Total Debt for Q1 2026 came in at $1.5 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (changed N/A YoY), and the FY2023 annual result was $290.7 million, down 0.87% from the prior year.
  • Total Debt advanced to $1.5 billion in Q1 2026 per ALKS's latest filing, from $288.8 million in the prior quarter.
  • Over five years, Total Debt peaked at $1.5 billion in Q1 2026 and troughed at $288.8 million in Q3 2024.
  • A 4-year average of $393.5 million and a median of $292.3 million in 2023 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2022 and 2024: Total Debt dropped 0.85% in 2022, then retreated 0.87% in 2024.
  • A 4-year view of Total Debt shows it stood at $293.3 million in 2022, then fell by 0.87% to $290.7 million in 2023, then slipped by 0.66% to $288.8 million in 2024, then surged by 422.93% to $1.5 billion in 2026.
  • Business Quant data shows ALKS's Total Debt at $1.5 billion in Q1 2026, $288.8 million in Q3 2024, and $289.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.63 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 9.05 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.53 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 3.99 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.51 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 570.41 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Bn
Sep 30, 2024 288.82 Mn
Jun 30, 2024 289.46 Mn
Mar 31, 2024 290.10 Mn
Dec 31, 2023 290.73 Mn
Sep 30, 2023 291.37 Mn
Jun 30, 2023 292.00 Mn
Mar 31, 2023 292.64 Mn
Dec 31, 2022 293.27 Mn
Sep 30, 2022 293.90 Mn
Jun 30, 2022 294.54 Mn
Mar 31, 2022 295.17 Mn
Dec 31, 2021 295.80 Mn
Sep 30, 2021 296.44 Mn
Jun 30, 2021 297.07 Mn
Mar 31, 2021 297.70 Mn
Dec 31, 2020 274.96 Mn
Sep 30, 2020 275.51 Mn
Jun 30, 2020 276.05 Mn
Mar 31, 2020 276.59 Mn